CA Stock MarketDetailed Quotes
XTCY Xtacy Therapeutics Corp
- 0.040
- +0.005+14.29%
15min DelayMarket Closed Jun 28 10:52 ET
2.18MMarket Cap-4000P/E (TTM)
0.040High0.040Low1.20MVolume0.040Open0.035Pre Close48.00KTurnover0.11552wk High2.29%Turnover Ratio54.58MShares0.02052wk Low-0.01EPS TTM2.09MFloat Cap0.115Historical HighLossP/E (Static)52.30MShs Float0.020Historical Low-0.01EPS LYR0.00%Amplitude--Dividend TTM-1.60P/B1Lot Size--Div YieldTTM
Xtacy Therapeutics Corp Key Stats
Quarterly+Annual
YOY
| (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | (Q3)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 24.27K | 0 | 21.83K | 21.83K | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --24.27K | --0 | --21.83K | --21.83K | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 38.46%2.66K | 24.84%2.4K | -14.32%2.29K | -362.54%-4.35K | 2.78K | 634.35%1.92K | 156.53%1.92K | 76.39%2.67K | 9.46%1.66K | 0 |
| Gross profit | 1,222.87%21.6K | -24.84%-2.4K | 832.66%19.54K | 1,681.27%26.17K | -2.78K | -634.35%-1.92K | -156.53%-1.92K | -76.39%-2.67K | -9.46%-1.66K | 0 |
| Operating expense | -66.57%87.33K | 77.14%263.44K | -31.66%939.67K | -46.88%134.17K | -47.10%395.51K | 105.23%261.27K | -39.89%148.72K | -64.55%1.38M | -90.49%252.58K | 2.30%747.72K |
| Selling and administrative expenses | -64.40%84.58K | 83.91%250.78K | -31.00%856.71K | -52.57%112.75K | -46.85%370.06K | 112.74%237.54K | -30.44%136.36K | -67.36%1.24M | -91.00%237.74K | -3.02%696.22K |
| -Selling and marketing expense | --0 | ---- | --0 | --0 | --0 | --0 | ---- | 114.12%482.5K | --180K | 10.95%250K |
| -General and administrative expense | -64.40%84.58K | 83.91%250.78K | 12.85%856.71K | 95.27%112.75K | -17.07%370.06K | 301.54%237.54K | -30.44%136.36K | -78.79%759.14K | -97.81%57.74K | -9.41%446.22K |
| Other operating expenses | -88.38%2.76K | 2.46%12.67K | -37.79%82.96K | 44.40%21.42K | -50.58%25.45K | 51.63%23.73K | -75.94%12.36K | 79.05%133.37K | 1.49%14.84K | 296.88%51.5K |
| Operating profit | 75.03%-65.73K | -76.47%-265.84K | 33.21%-920.13K | 57.52%-108K | 46.73%-398.29K | -106.32%-263.19K | 39.29%-150.64K | 64.50%-1.38M | 90.43%-254.23K | -2.30%-747.72K |
| Net non-operating interest income (expenses) | 0 | 0 | 41.10%-1.13K | 0 | 0 | 23.85%-578 | -45.03%-554 | -22.34%-1.92K | 10.67%-385 | -3.39%-397 |
| Total other finance cost | ---- | ---- | -41.10%1.13K | --0 | ---- | -23.85%578 | 45.03%554 | 22.34%1.92K | -10.67%385 | 3.39%397 |
| Other net income (expenses) | 3,593.10%401.33K | 125.68%367.31K | 35.78K | 80.91%-358 | 99.20%-1.4K | -96.35%10.87K | -15.27%162.76K | |||
| Gain on sale of security | ---- | ---- | -439.53%-3.02K | -611.79%-1.26K | ---- | 54.80%-358 | ---1.4K | 18.75%-559 | 173.87%246 | ---- |
| Special income (charges) | ---- | ---- | 3,438.81%404.35K | 126.80%368.57K | --35.78K | ---- | ---- | -96.18%11.43K | --162.51K | --0 |
| -Less:Other special charges | ---- | ---- | -114.87%-24.55K | 106.91%11.22K | ---35.78K | ---- | ---- | 96.18%-11.43K | ---162.51K | ---- |
| -Less:Write off | ---- | ---- | ---379.79K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Income before tax | 75.12%-65.73K | -74.21%-265.84K | 62.01%-519.94K | 382.28%259.31K | 51.54%-362.52K | -102.86%-264.13K | 63.97%-152.6K | 61.81%-1.37M | 96.28%-91.86K | -22.52%-748.12K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 75.12%-65.73K | -74.21%-265.84K | 62.01%-519.94K | 382.28%259.31K | 51.54%-362.52K | -102.86%-264.13K | 63.97%-152.6K | 61.81%-1.37M | 96.28%-91.86K | -22.52%-748.12K |
| Net income continuous operations | 75.12%-65.73K | -74.21%-265.84K | 62.01%-519.94K | 382.28%259.31K | 51.54%-362.52K | -102.86%-264.13K | 63.97%-152.6K | 61.81%-1.37M | 96.28%-91.86K | -22.52%-748.12K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 75.12%-65.73K | -74.21%-265.84K | 62.01%-519.94K | 382.28%259.31K | 51.54%-362.52K | -102.86%-264.13K | 63.97%-152.6K | 61.81%-1.37M | 96.28%-91.86K | -22.52%-748.12K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 75.12%-65.73K | -74.21%-265.84K | 62.01%-519.94K | 382.28%259.31K | 51.54%-362.52K | -102.86%-264.13K | 63.97%-152.6K | 61.81%-1.37M | 96.28%-91.86K | -22.52%-748.12K |
| Diluted earnings per share | 87.96%-0.0012 | -146.18%-0.01 | 80.00%-0.01 | 0.01 | 66.67%-0.01 | 0.00%-0.01 | 79.69%-0.0041 | 78.26%-0.05 | 0 | 25.00%-0.03 |
| Basic earnings per share | 87.96%-0.0012 | -146.18%-0.01 | 80.00%-0.01 | 0.01 | 66.67%-0.01 | 0.00%-0.01 | 79.69%-0.0041 | 78.26%-0.05 | 0 | 25.00%-0.03 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg